Marksans Pharma fundamental analysis
MARKSANS
173.97
4.89 (-2.73%)Last updated on 9 Jan, 2026 | 15:31 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Marksans Pharma Fundamentals
P/E Ratio
22.41
P/B Ratio
2.93
Div. Yield
0.46
Sector P/E
69.98
Sector P/B
0.95
Sec. Div. Yield
0.57
Marksans Pharma Fundamentals is currently trading with a P/E Ratio of 22.41, compared to the sector average of 69.98. Its P/B Ratio stands at 2.93, while the sector’s is 0.95. In terms of returns, the stock offers a Dividend Yield of 0.46%, which is than the sector’s 0.57%.
Marksans Pharma Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Marksans Pharma reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
